![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A01N 25/00 | (2006.01) |
A61K 38/00 | (2006.01) |
(11) | Number of the document | 3288379 |
(13) | Kind of document | T |
(96) | European patent application number | 16789830.3 |
Date of filing the European patent application | 2016-04-29 | |
(97) | Date of publication of the European application | 2018-03-07 |
(45) | Date of publication and mention of the grant of the patent | 2021-11-03 |
(46) | Date of publication of the claims translation | 2022-02-25 |
(86) | Number | PCT/US2016/030098 |
Date | 2016-04-29 |
(87) | Number | WO 2016/178993 |
Date | 2016-11-10 |
(30) | Number | Date | Country code |
201562155711 P | 2015-05-01 | US |
(72) |
BESIRLI, Cagri, G. , US
BRIDGES, Alexander, J. , US
FRESHLEY, John, K. , US
HUNKE, William, A. , US
JOHNSON, Linda, L. , US
SMITH, Francis, X. , US
SYLVAIN, Ethan , US
ZACKS, David, N. , US
|
(73) |
ONL Therapeutics, Inc. ,
524 S. Main St., Ste 110, Ann Arbor, MI 48104,
US
The Regents of the University of Michigan , Office of Technology Transfer 1600 Huron Parkway, 2nd Floor, Ann Arbor, MI 48109-2590, US |
(74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
(54) | Peptidų kompozicijos ir naudojimo būdai |
PEPTIDE COMPOSITIONS AND METHODS OF USE |
Payment date | Validity (years) | Amount | |
2025-04-01 | 10 | 231.00 EUR |
2026-04-29 |